Extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease.
- Author:
Ji-Yin ZHU
;
Rui JIANG
- Publication Type:Journal Article
- MeSH:
Erectile Dysfunction;
therapy;
High-Energy Shock Waves;
therapeutic use;
Humans;
Male;
Penile Induration;
therapy
- From:
National Journal of Andrology
2014;20(9):846-849
- CountryChina
- Language:Chinese
-
Abstract:
Penile vascular endothelial damage, vasomotor dysfunction, and blood flow deficiency are the major causes of erectile dysfunction (ED). Current management of ED mostly depends on selective phosphodiesterase type 5- (PDE5) inhibitors, which fail for some ED patients. For Peyronie's disease-induced ED, surgical and physical therapies are used in addition to PDE5I medication, but frequently it is difficult to achieve satisfactory results. Recent studies show that the low-intensity extracorporeal shockwave therapy can promote angiogenesis and improve blood flow to the penis, which promises to be a novel effective therapy for ED and Peyronie's disease.
